Due to overexpression of transferrin receptor in GPC3-positive HCC patients, the iron content of the tumor increases (24, 25), making the R2* map potentially an excellent way for evaluating GPC3 status in HCC. The gene discussed is TFRC; the disease is hepatocellular carcinoma.